* NU Skin Enterprises Inc NUS.N NUS is expected to show
a fall
in quarterly revenue when it reports results on February 15.
* The Provo Utah-based company is expected to report a
19.5% decrease in revenue to $542.318 million from $673.44
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. The company's guidance on
November 2 2022, for the period ended December 31, was for
revenue between $500.00 million and $550.00 million.
* Refinitiv's mean analyst estimate for NU Skin Enterprises
Inc
is for earnings of 53 cents per share. The company's EPS
guidance on November 2 2022, for the period ended December
31, was between $0.40 and $0.60
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for NU Skin
Enterprises Inc is $39, below its last closing price
of $43.74.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.78 0.78 0.47 Missed -39.6
Jun. 30 2022 0.76 0.75 0.77 Beat 2.3
Mar. 31 2022 0.72 0.72 0.76 Beat 5.8
Dec. 31 2021 0.95 0.95 1.11 Beat 17.3
Sep. 0.88 0.86 0.97 Beat 12.9
30 2021
Jun. 30 2021 1.06 1.05 1.15 Beat 10
Mar. 31 2021 0.73 0.72 0.91 Beat 26
Dec. 31 2020 1.18 1.19 1.40 Beat 17.9
This summary was machine generated February 14 at 03:02 GMT.
All figures in US dollars unless otherwise stated